Literature DB >> 22220676

Results of kidney transplantation from controlled donors after cardio-circulatory death: a single center experience.

Hieu Ledinh1, Laurent Weekers, Catherine Bonvoisin, Jean-Marie Krzesinski, Josée Monard, Arnaud de Roover, Jean Paul Squifflet, Michel Meurisse, Olivier Detry.   

Abstract

The aim of this study was to determine results of kidney transplantation (KT) from controlled donation after cardio-circulatory death (DCD). Primary end-points were graft and patient survival, and post-transplant complications. The influence of delayed graft function (DGF) on graft survival and DGF risk factors were analyzed as secondary end-points. This is a retrospective mono-center review of a consecutive series of 59 DCD-KT performed between 2005 and 2010. Overall graft survival was 96.6%, 94.6%, and 90.7% at 3 months, 1 and 3 years, respectively. Main cause of graft loss was patient's death with a functioning graft. No primary nonfunction grafts. Renal graft function was suboptimal at hospital discharge, but nearly normalized at 3 months. DGF was observed in 45.6% of all DCD-KT. DGF significantly increased postoperative length of hospitalization, but had no deleterious impact on graft function or survival. Donor body mass index ≥30 was the only donor factor that was found to significantly increase the risk of DGF (P < 0.05). Despite a higher rate of DGF, controlled DCD-KT offers a valuable contribution to the pool of deceased donor kidney grafts, with comparable mid-term results to those procured after brain death. Transplant International © Michel Meurisse.

Entities:  

Mesh:

Year:  2011        PMID: 22220676     DOI: 10.1111/j.1432-2277.2011.01402.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  1 in total

1.  Five-year experience with donation after cardiac death kidney transplantation in a Canadian transplant program: Factors affecting outcomes.

Authors:  Michael Moser; Michael Sharpe; Corinne Weernink; Harrison Brown; Thomas McGregor; Andrew A House; Patrick P Luke
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.